Published 2011 | Version v1
Publication

Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors

Additional details

Created:
April 14, 2023
Modified:
November 27, 2023